Comparing Gamunex-C vs Vyvgart
| Gamunex-C (immune globulin intravenous and subcutaneous) | Vyvgart (efgartigimod alfa) |
|
|---|
| Gamunex-C (immune globulin intravenous and subcutaneous) | Vyvgart (efgartigimod alfa) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Primary Immunodeficiency Syndrome, Immune Thrombocytopenia. Gamunex-C may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Myasthenia Gravis. Vyvgart may also be used for purposes not listed in this medication guide. |
||||||||||||||||
| More about Gamunex-C (immune globulin intravenous and subcutaneous) | More about Vyvgart (efgartigimod alfa) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Gamunex-C has an average rating of 8.2 out of 10 from a total of 13 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 8% reported a negative effect. |
Vyvgart has an average rating of 8.5 out of 10 from a total of 15 ratings on Drugs.com. 87% of reviewers reported a positive effect, while 7% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Gamunex-C side effects |
View all Vyvgart side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Gamunex-C prices |
View all Vyvgart prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other immune globulin intravenous and subcutaneous brands include: Gammagard Liquid, Gammaked |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
857.76 hours |
120 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 105 drugs are known to interact with Gamunex-C:
|
A total of 293 drugs are known to interact with Vyvgart:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
December 17, 2021 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.